3/11/2014 9:07:15 AM
TARRYTOWN, N.Y., March 10, 2014 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc., (Nasdaq:PGNX), an oncology company focused on developing innovative ways to target and treat prostate cancer, announced today that it will host a conference call and webcast to review fourth quarter and full-year 2013 financial results on Thursday, March 13, at 8:30 a.m. ET.
Help employers find you! Check out all the jobs and post your resume.
comments powered by